Profund Advisors LLC Sarepta Therapeutics, Inc. Transaction History

Profund Advisors LLC

  • $2.97 Billion
  • Q3 2025

A detailed history of Profund Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 38,874 shares of SRPT stock, worth $731,219. This represents 0.03% of its overall portfolio holdings.

Number of Shares
38,874
Previous 31,789 22.29%
Holding current value
$731,219
Previous $543,000 37.94%
% of portfolio
0.03%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025
BUY
$11.93 - $21.97 $84,524 - $155,657
7,085 Added 22.29%
38,874 $749,000
Q2 2025

Aug 07, 2025
BUY
$17.1 - $63.66 $173,753 - $646,849
10,161 Added 46.98%
31,789 $543,000
Q1 2025

May 08, 2025
SELL
$63.82 - $127.89 $24,825 - $49,749
-389 Reduced 1.77%
21,628 $1.38 Million
Q4 2024

Feb 13, 2025
SELL
$104.54 - $137.94 $664,665 - $877,022
-6,358 Reduced 22.41%
22,017 $2.68 Million
Q3 2024

Nov 13, 2024
BUY
$124.33 - $156.75 $9,697 - $12,226
78 Added 0.28%
28,375 $3.54 Million
Q2 2024

Aug 13, 2024
BUY
$113.33 - $163.85 $1.94 Million - $2.81 Million
17,132 Added 153.44%
28,297 $4.47 Million
Q1 2024

May 08, 2024
SELL
$93.7 - $141.53 $478,994 - $723,501
-5,112 Reduced 31.41%
11,165 $1.45 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $275,095 - $509,894
4,087 Added 33.53%
16,277 $1.57 Million
Q3 2023

Nov 13, 2023
BUY
$102.5 - $123.59 $65,395 - $78,850
638 Added 5.52%
12,190 $1.48 Million
Q2 2023

Aug 10, 2023
BUY
$106.4 - $157.19 $314,944 - $465,282
2,960 Added 34.45%
11,552 $1.32 Million
Q1 2023

May 11, 2023
SELL
$117.53 - $155.99 $141,036 - $187,188
-1,200 Reduced 12.25%
8,592 $1.18 Million
Q4 2022

Feb 02, 2023
BUY
$100.86 - $132.13 $24,508 - $32,107
243 Added 2.54%
9,792 $1.27 Million
Q3 2022

Nov 04, 2022
SELL
$75.71 - $119.24 $33,993 - $53,538
-449 Reduced 4.49%
9,549 $1.06 Million
Q2 2022

Aug 01, 2022
SELL
$62.69 - $88.44 $53,286 - $75,174
-850 Reduced 7.84%
9,998 $749,000
Q1 2022

May 10, 2022
SELL
$63.15 - $90.42 $71,170 - $101,903
-1,127 Reduced 9.41%
10,848 $847,000
Q4 2021

Feb 08, 2022
SELL
$77.28 - $99.42 $75,348 - $96,934
-975 Reduced 7.53%
11,975 $1.08 Million
Q3 2021

Nov 12, 2021
SELL
$65.97 - $92.48 $43,870 - $61,499
-665 Reduced 4.88%
12,950 $1.2 Million
Q2 2021

Aug 12, 2021
SELL
$69.38 - $86.75 $26,156 - $32,704
-377 Reduced 2.69%
13,615 $1.06 Million
Q1 2021

May 14, 2021
SELL
$72.25 - $168.95 $150,858 - $352,767
-2,088 Reduced 12.99%
13,992 $1.04 Million
Q4 2020

Feb 09, 2021
BUY
$125.56 - $178.74 $186,331 - $265,250
1,484 Added 10.17%
16,080 $2.74 Million
Q3 2020

Nov 13, 2020
SELL
$127.12 - $172.34 $231,739 - $314,175
-1,823 Reduced 11.1%
14,596 $2.05 Million
Q2 2020

Aug 03, 2020
BUY
$93.0 - $171.7 $289,695 - $534,845
3,115 Added 23.41%
16,419 $2.63 Million
Q1 2020

May 15, 2020
SELL
$82.38 - $131.64 $399,872 - $638,980
-4,854 Reduced 26.73%
13,304 $1.3 Million
Q4 2019

Feb 18, 2020
BUY
$76.53 - $135.58 $145,789 - $258,279
1,905 Added 11.72%
18,158 $2.34 Million
Q3 2019

Nov 12, 2019
SELL
$72.81 - $156.91 $66,839 - $144,043
-918 Reduced 5.35%
16,253 $1.22 Million
Q2 2019

Aug 13, 2019
SELL
$112.21 - $151.95 $145,311 - $196,775
-1,295 Reduced 7.01%
17,171 $2.61 Million
Q1 2019

May 15, 2019
BUY
$106.67 - $151.68 $26,454 - $37,616
248 Added 1.36%
18,466 $2.2 Million
Q4 2018

Feb 14, 2019
SELL
$97.32 - $148.76 $304,125 - $464,875
-3,125 Reduced 14.64%
18,218 $1.99 Million
Q3 2018

Nov 13, 2018
BUY
$115.31 - $161.51 $2.46 Million - $3.45 Million
21,343 New
21,343 $3.45 Million

Others Institutions Holding SRPT

# of Institutions
406
Shares Held
83.7M
Call Options Held
5.27M
Put Options Held
5.94M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.65B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email